The Use of Vestibular Tests for the Selection of Anti-vertigo Drugs
- 1 January 1988
- journal article
- research article
- Published by Taylor & Francis in Acta Oto-Laryngologica
- Vol. 105 (sup460) , 94-98
- https://doi.org/10.3109/00016488809125141
Abstract
Vertigo is not a disease, but a symptom. Therefore, the therapy of vertigo is primarily directed at eliminating the underlying cause. In about half of the cases the cause will not become apparent, however, and the therapy is doomed to be symptomatic. Several types of drugs have been found to have an anti-vertigo activity, e.g. antihistamines, calcium antagonists, anti-emetics. For the selection of vestibular depressants, the vestibular caloric test and the rotation test can be used. The duration of the nystagmus induced by rotation is the most useful parameter. The lag-period, the extent and duration of the vestibular effects can be determined and compared with that of other substances. A stronger action on a nystagmus does not necessarily mean a stronger anti-vertiginous action. The final proof of an anti-vertiginous activity can only be established in clinical studies in patients with vertigo.Keywords
This publication has 3 references indexed in Scilit:
- Vertigo Current Concepts in ManagementDrugs, 1985
- The Vertiginous SyndromePublished by S. Karger AG ,1982
- A comparative study of the effects of cinnarizine, sulpiride and thiethylperazine on vestibular nystagmus in rabbitsEuropean Journal of Pharmacology, 1978